Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2015

Conditions
Depression
Interventions
PROCEDURE

ECT

ECT was administered twice a week with a constant-current brief-pulse device (Thymatron, System IV). Motor and electroencephalographic seizures were monitored to ensure adequate duration and quality. Subjects were all treated with right unilateral (RUL) ECT with stimulus intensity 6 times the initial seizure threshold (ST), as determined by empirical dose titration at the first treatment, until remission (Montgomery-Åsberg Depression Rating Scale (MADRS) (27) \< 10 in two consecutive ratings with a week interval). Subjects who failed to respond right unilateral ECT after the sixth treatment were switched to bitemporal ECT (1.5x seizure threshold).

DRUG

Etomidate

Anesthesia was achieved with intravenous administration of etomidate (0.2mg/kg).

DRUG

Succinylcholine

Anesthesia was achieved with intravenous administration of succinylcholine (1mg/kg).

All Listed Sponsors
collaborator

VU University of Amsterdam

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02667353 - Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression | Biotech Hunter | Biotech Hunter